Dabur clarifies USFDA observations at Silvassa plant
DABUR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.2 pts less than Nifty Midcap 150 and 3.1 pts less than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dabur clarified that USFDA observations on data integrity and maintenance lapses concern only a small part of its Silvassa plant, which generates insignificant revenue. The plant remains operational. The company has shared a corrective and preventive action plan with USFDA and is providing regular updates. Dabur stated there is no impact on its financials, operations, or other activities from the matter.
Likely limited impact as the affected plant contributes insignificant revenue and operations continue. May weigh on stock sentiment in the short term.